Frank Neumann
'Can't say no': Kite Pharma taps Frank Neumann as new head of clinical development
Kite Pharma hit a major landmark in July when it got a second FDA OK, creating the first commercial CAR-T portfolio. But a biotech’s work …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
